Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Inovio Pharma

Start price
Target price
Perf. (%)
€6.92
10.07.21
€5.80
10.07.22
-6.86%
27.11.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
geldnutzer 
10.07.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€21.24
15.11.21
€25.00
15.11.22
33.24%
27.11.21

Fair valuation
Very Future proof/growth oriented business model
Could be very worthwhile Investment >20% year
Higher risks for its business
skatcup 
15.11.21 90%
buy
Novo Nordisk A/S

Start price
Target price
Perf. (%)
€100.08
16.11.21
-
16.11.22
-5.88%
27.11.21

gerihouse 
16.11.21 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€23.97
15.11.21
-
15.11.22
-28.16%
26.11.21

Could be worthwhile Investment >10% per year
Vassago1 
15.11.21 50%
sell
Boiron S.A.

Start price
Target price
Perf. (%)
€38.55
13.04.21
€36.00
13.04.22
-1.30%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
13.04.21 50%
sell
Avid Bioservices Inc

Start price
Target price
Perf. (%)
€20.60
17.06.21
€17.00
17.06.22
38.84%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
17.06.21 50%
buy
Abeona Therapeutics Inc.

Start price
Target price
Perf. (%)
€19.80
17.10.21
€25.00
17.10.22
-15.53%
26.11.21

Could be worthwhile Investment >10% per year
melinda 
17.10.21 50%
sell
Valneva SE

Start price
Target price
Perf. (%)
€24.38
25.11.21
€21.00
25.11.22
6.64%
26.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
25.11.21 50%
sell
Incyte Corp.

Start price
Target price
Perf. (%)
€67.64
24.02.21
-
24.02.22
-12.39%
25.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
SpringheelJack 
24.02.21 50%
sell
Incyte Corp.

Start price
Target price
Perf. (%)
€67.64
24.02.21
-
24.02.22
-12.39%
25.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Dependend from some customers or products
SpringheelJack 
24.02.21 50%
buy
Valneva SE

Start price
Target price
Perf. (%)
€11.24
20.07.21
€20.00
20.07.22
116.90%
25.11.21

Could be worthwhile Investment >10% per year
Very valuable balance sheet
melinda 
20.07.21 50%
buy
Poxel S.A.

Start price
Target price
Perf. (%)
€5.86
07.10.21
€7.50
07.10.22
-8.28%
24.11.21

Could be worthwhile Investment >10% per year
melinda 
07.10.21 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
23.11.20 80%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
23.11.20 80%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€442.80
23.11.20
€555.00
23.11.21
29.97%
24.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
geldnutzer 
23.11.20 80%
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
22.11.20
€73.00
22.11.21
-0.41%
23.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
Konrad 
22.11.20 50%
buy
Bayer AG

Start price
Target price
Perf. (%)
€48.20
22.11.20
€73.00
22.11.21
-0.41%
23.11.21

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Undervalued
Very high dividend yield expected
Konrad 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

marge 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

marge 
22.11.20 50%
buy
Regeneron Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€529.00
22.11.20
€500.00
22.11.21
7.75%
23.11.21

marge 
22.11.20 50%
sell
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.24
17.11.21
€1.80
17.11.22
0.00%
19.11.21

Could be worthwhile Investment >10% per year
melinda 
17.11.21 50%
buy
Kazia Therapeutics ADR

Start price
Target price
Perf. (%)
€10.50
19.11.20
-
19.11.21
-28.57%
19.11.21

Risky Investment
Langfinger 
19.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
45.06%
19.11.21

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
shadow 
18.11.20 50%
buy
Pfizer Inc.

Start price
Target price
Perf. (%)
€31.40
18.11.20
-
18.11.21
45.06%
19.11.21

EBIT growth >5% per year expected
Higher EBIT margin than peer group
Fair valuation
Low dividend yield expected
shadow 
18.11.20 50%
buy
Erytech Pharma S.A.

Start price
Target price
Perf. (%)
€2.19
11.11.21
-
11.11.22
2.28%
17.11.21

Could be worthwhile Investment >10% per year
melinda 
11.11.21 0%